
160 - Addressing Impurities and By-Products in Pharmaceutical Process Development (S11E10)
About this episode
This episode explores the strategies and analytical techniques employed to identify, control, and manage impurities and by-products during the development and manufacturing of drug substances. The importance of strategic planning is laid out in the beginning, and then leads into the different methods of making the base and how things are extracted and pulled from the substance. How the analytical chemicals play into making new formulas, methods and procedures
The discussion delves into the importance of Genotoxic Impurities and their specific need to be removed, and what happens when they don't. How specific chemicals need certain methods for their creation that are difficult to replace, etc. The conversation then hits back to the good and consistent nature of manufacturing with that of purity. the discussion is about analytical tools, testing and everything that would be needed in the manufacturing process.
Get every episode summarized
Each time From Concept to Medicine - A Comprehensive Drug Development Journey publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from From Concept to Medicine - A Comprehensive Drug Development Journey

21 Atorvastatin (S24E21)
From Concept to Medicine - A Comprehensive Drug Development Journey

185 - Episode 5 - Good Documentation Practices (GDP) in Medical Devices - The AL...
From Concept to Medicine - A Comprehensive Drug Development Journey

20 Liraglutide (S24E20)
From Concept to Medicine - A Comprehensive Drug Development Journey

18 Pioglitazone (S24E18)
From Concept to Medicine - A Comprehensive Drug Development Journey